Exofin Precision Pen
Tissue Adhesive For The Topical Approximation Of Skin. 510(k) K212246, from Chemence Medical, Inc. (Alpharetta, GA). Product code MPN, class 2.
As of Nov 21, 2026, K212246 is an FDA 510(k) held by Chemence Medical, Inc., substantially equivalent on Sep 9, 2021 after 52 days, with no recalls tied to it in FDA's recall database.
- Review time: 52 days
- Recalls: 0
Exofin® Precision Pen is intended for topical application only to hold closed easily approximated skin edges of wounds from surgical incisions, including incisions from minimally invasive surgery, and simple, thoroughly cleansed, trauma-induced lacerations. Exofin® Precision Pen may be used in conjunction with, but not in place of, deep dermal sutures.
- Exofin High Viscosity Topical Skin AdhesiveK200264 · Chemence Medical, Inc. · Dec 17, 2020
- BondEase 2 Topical Skin AdhesiveK243990 · Optmed, Inc. · Sep 19, 2025
- CUTIVA™ Topical Skin Adhesive (RM1700); CUTIVA™ PLUS Skin Closure System (RM1739)K250950 · Okapi Medical, LLC Dba Resivant Medical · Aug 4, 2025
- CUTIVA(TM) Topical Skin Adhesive (RM-1700); CUTIVA(TM) PLUS Skin Closure System (RM-1739)K234114 · Okapi Medical, LLC Dba Resivant Medical · Aug 20, 2024
- CM005 Standard (CM005); CM004 Mini (CM004)K233458 · Connexicon Medical , Ltd. · Jul 15, 2024
- Meriglu Topical Skin AdhesiveK230981 · M/s. Meril Endo Surgery Private Limited. · Mar 16, 2024
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Jul 19, 2021
- Review panel
- General, Plastic Surgery
- Regulation
- 21 CFR 878.4010
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files